Skip to content
Disclosery

EXANE DERIVATIVES: NUE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NUE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 5,256 NUE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 5,256 shares
    Change vs previous 13F +884 shares

    0.32% of the 13F portfolio, value $548,721.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 4,372 shares
    Change vs previous 13F +1,239 shares

    0.18% of the 13F portfolio, value $649,902.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,133 shares
    Change vs previous 13F -90 shares

    0.09% of the 13F portfolio, value $357,643.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,223 shares
    Change vs previous 13F -3,716 shares

    0.08% of the 13F portfolio, value $317,446.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 6,939 shares
    Change vs previous 13F +6,805 shares

    0.16% of the 13F portfolio, value $661,301.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 134 shares
    Change vs previous 13F -1,055 shares

    <0.01% of the 13F portfolio, value $10,757.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,189 shares
    Change vs previous 13F -758 shares

    0.02% of the 13F portfolio, value $63,246.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,947 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $87,345.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).